TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

AMTA

CardiovascularNeurologyImmunology
Generics

AMTA is a generic drug manufacturer focused on Cardiovascular, Neurology, Immunology.

2020
Since
5
Drugs
-
Trials
97
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
TOPIRAMATE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
DILTIAZEM HYDROCHLORIDE 2026-02-23
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 25%
1 drugs
Neurology 25%
1 drugs
Immunology 25%
1 drugs
Gastroenterology 25%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Bristol-Myers Squibb big-pharma
Immunology, Gastroenterology, Neurology
BAUSCH specialty
Immunology, Cardiovascular, Gastroenterology
Takeda big-pharma
Immunology, Gastroenterology, Neurology
Pfizer big-pharma
Immunology, Gastroenterology
PAI HOLDINGS PHARM big-pharma
Neurology, Cardiovascular, Immunology